Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Sinocompound Corporation
Sinocompound Corporation
Activities:
Ingredients
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Regulatory
Sinocompound signs non-PGM catalyst licensing agreement with Dalhousie Uni
Sinocompound Catalysts Co. has announced a new licensing agreement for a range of novel non-platinum group metal (non-PGM) catalysts from Dalhousie University, Canada
Manufacturing
Sinocompound announces QPhos ligand commercial production
QPhos is a reportedly promising ligand in metal-catalysed cross-coupling reactions, fundamental to construct carbon-based bonds featured in most drug scaffolds
Manufacturing
Catalyst expert Sinocompound launches educational video series
The video series aim to help problem-solve some of the issues that occur most frequently in industry
Subscribe now